Quantumzyme Responds to OTC Markets Caveat Emptor Designation, Denies Unauthorized Promotional Activity
TL;DR
Quantumzyme Corp. is addressing concerns with OTC Markets for a positive impact on stock reputation.
Quantumzyme Corp. is working with OTC Markets to resolve issues and maintain market integrity.
Quantumzyme Corp. aims to protect its reputation, ensure transparency, and deliver long-term value to shareholders.
Quantumzyme Corp. combines quantum mechanics and AI to revolutionize chemical processes for sustainability and efficiency.
Found this article helpful?
Share it with your network and spread the knowledge!

Quantumzyme Corp., a biotechnology company specializing in computational enzyme engineering, is actively addressing a Caveat Emptor designation placed on its securities by OTC Markets Group. The company has immediately initiated contact with OTC Markets to understand and resolve the underlying concerns.
CEO Naveen Kulkarni stated that the company is committed to working cooperatively and swiftly to have the Caveat Emptor status removed. To support this effort, Quantumzyme has retained legal counsel to help resolve the matter promptly.
In a separate but related development, the company strongly denies any connection to unauthorized promotional SMS text messages that mentioned Quantumzyme. The firm unequivocally states it did not authorize, endorse, or have prior knowledge of these messages and will fully cooperate with any regulatory reviews.
The Caveat Emptor designation and unauthorized promotional activity could potentially impact investor confidence and the company's market reputation. By proactively addressing these issues, Quantumzyme aims to demonstrate transparency and maintain its commitment to regulatory compliance.
The company remains focused on its core mission of delivering sustainable, enzyme-based solutions through advanced computational modeling and biocatalysis technologies. Quantumzyme will provide updates as the situation develops and continues to prioritize long-term value creation for its shareholders.
Curated from NewMediaWire

